Publications
Detailed Information
Radioiodine gene therapy of hepatocellular carcinoma targeted human alpha fetoprotein
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jin, Yong Nan | - |
dc.contributor.author | Chung, Hye Kyung | - |
dc.contributor.author | Kang, Joo Hyun | - |
dc.contributor.author | Lee, Yong Jin | - |
dc.contributor.author | Kimm, Kwang Il | - |
dc.contributor.author | Kim, Young Joo | - |
dc.contributor.author | Kim, Seunghoo | - |
dc.contributor.author | Chung, June-Key | - |
dc.date.accessioned | 2010-06-22T07:56:27Z | - |
dc.date.available | 2010-06-22T07:56:27Z | - |
dc.date.issued | 2008-11-07 | - |
dc.identifier.citation | Cancer Biother Radiopharm. 2008;23(5):551-560 | en |
dc.identifier.issn | 1557-8852 (Electronic) | - |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18986218 | - |
dc.identifier.uri | https://hdl.handle.net/10371/67758 | - |
dc.description.abstract | INTRODUCTION: We conducted a molecular imaging and gene therapy method in alpha-fetoprotein (AFP)-producing hepatocellular carcinoma (HCC) by tumor-specific expression of the human sodium/iodide symporter (hNIS) using an AFP promoter. METHODS: The tumor-specific expression of hNIS gene by the AFP enhancer/promoter was constructed as pcDNA3-AFP/hNIS. The pcDNA3-AFP/hNIS was stably transfected to human HCC (Huh-7/AN) and rat glioma cells (C6/AN). Functional hNIS expression was confirmed by radioiodine uptake. The mRNA and protein-expression level of hNIS were measured. Biodistribution of 131I was evaluated, and scintigraphic images of 99mTc were obtained in xenografted mice. A clonogenic assay was performed by 131I. And, the in vivo therapeutic effect of 131I was evaluated in xenografted mice. RESULTS: In Huh-7/AN cells, iodine was highly accumulated and completely blocked by perchlorate. The protein and mRNA expression levels were correlated with iodine uptake. Radioiodine uptake in Huh-7/AN tumors was higher than those of control tumors and clearly visualized. The survival rate was significantly decreased in Huh-7/AN cells by 131I. Moreover, a growth of Huh-7/AN tumors was inhibited by 131I in mice. CONCLUSIONS: AFP-producing hepatoma can be targeted and treated with radionuclides and hNIS, using AFP enhancer/promoter. This targeted hNIS gene therapy and molecular imaging have the potential to be used in the management of AFP-producing HCC. | en |
dc.language.iso | en | en |
dc.publisher | Mary Ann Liebert | en |
dc.subject | Animals | en |
dc.subject | Carcinoma, Hepatocellular/*radiotherapy/*therapy | en |
dc.subject | Cell Line, Tumor | en |
dc.subject | Enhancer Elements, Genetic | en |
dc.subject | Gene Therapy/*methods | en |
dc.subject | Humans | en |
dc.subject | Iodine Radioisotopes/*pharmacology | en |
dc.subject | Liver Neoplasms/*radiotherapy/*therapy | en |
dc.subject | Male | en |
dc.subject | Mice | en |
dc.subject | Mice, Inbred BALB C | en |
dc.subject | Neoplasm Transplantation | en |
dc.subject | Promoter Regions, Genetic | en |
dc.subject | Rats | en |
dc.subject | Technetium/metabolism | en |
dc.subject | alpha-Fetoproteins/*biosynthesis | en |
dc.title | Radioiodine gene therapy of hepatocellular carcinoma targeted human alpha fetoprotein | en |
dc.type | Article | en |
dc.contributor.AlternativeAuthor | 진용난 | - |
dc.contributor.AlternativeAuthor | 정혜경 | - |
dc.contributor.AlternativeAuthor | 강주현 | - |
dc.contributor.AlternativeAuthor | 이용진 | - |
dc.contributor.AlternativeAuthor | 김광일 | - |
dc.contributor.AlternativeAuthor | 김영주 | - |
dc.contributor.AlternativeAuthor | 김승후 | - |
dc.contributor.AlternativeAuthor | 정준기 | - |
dc.identifier.doi | 10.1089/cbr.2008.0467 | - |
dc.identifier.doi | 10.1089/cbr.2008.0467 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.